Member Exclusive News

The week in industry: FDA approves the first treatment for children with Lambert-Easton myasthenic syndrome

This week: Drug manufacturers are now required to disclose drug prices on TV ads, Medicines Discovery Catapult (Cheshire, UK) and LifeArc (London, UK) partner to identify and develop novel biomarkers and the European Commission approves the use of PALYNZIQ® to treat Phenylketonuria.

Thumb untitled design
May 09, 2019
0
0

Please sign in or register for FREE

No comments yet.